PMID: 8962133Dec 10, 1996Paper

Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility

Proceedings of the National Academy of Sciences of the United States of America
W Weng, J L Breslow

Abstract

Apolipoprotein (apo) A-II is the second most abundant apolipoprotein in high density lipoprotein (HDL). To study its role in lipoprotein metabolism and atherosclerosis susceptibility, apo A-II knockout mice were created. Homozygous knockout mice had 67% and 52% reductions in HDL cholesterol levels in the fasted and fed states, respectively, and HDL particle size was reduced. Metabolic turnover studies revealed the HDL decrease to be due to both decreased HDL cholesterol ester and apo A-I transport rate and increased HDL cholesterol ester and apo A-I fractional catabolic rate. The apo A-II deficiency trait was bred onto the atherosclerosis-prone apo E-deficient background, which resulted in a surprising 66% decrease in cholesterol levels due primarily to decreased atherogenic lipoprotein remnant particles. Metabolic turnover studies indicated increased remnant clearance in the absence of apo A-II. Finally, apo A-II deficiency was associated with lower free fatty acid, glucose, and insulin levels, suggesting an insulin hypersensitivity state. In summary, apo A-II plays a complex role in lipoprotein metabolism, with some antiatherogenic properties such as the maintenance of a stable HDL pool, and other proatherogenic properties su...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·R WilliamsonN Maeda
Aug 1, 1990·The Journal of Clinical Investigation·A R Tall
Nov 1, 1987·Atherosclerosis·P PuchoisJ C Fruchart
Jan 1, 1986·Methods in Enzymology·A V NicholsT A Musliner
Nov 28, 1986·JAMA : the Journal of the American Medical Association·W P CastelliW B Kannel
Mar 1, 1982·The Journal of Cell Biology·H J GeuzeA L Schwartz
May 15, 1981·Biochemical and Biophysical Research Communications·M KuboS Tarui
Sep 24, 1981·Biochimica Et Biophysica Acta·P J BlancheA V Nichols
Sep 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·Y HuangG Assmann
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C H WardenY D Chen
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·Y NakashimaR Ross
Jul 1, 1957·Physics in Medicine and Biology·C M MATTHEWS

❮ Previous
Next ❯

Citations

Jun 19, 1998·Biochimica Et Biophysica Acta·S BraschiJ R Schultz
Jul 18, 2002·Atherosclerosis·Anne TailleuxVéronique Clavey
Oct 28, 1998·Progress in Cardiovascular Diseases·L M Belalcazar, C M Ballantyne
Oct 27, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·D CorellaJ M Ordovas
Oct 15, 2013·Assay and Drug Development Technologies·Manman SuDingding Wang
Aug 22, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Angelo M Scanu, Celina Edelstein
Apr 29, 2000·Current Opinion in Lipidology·A D Kalopissis, J Chambaz
May 29, 2004·Current Opinion in Lipidology·Jesús M Martín-CamposFrancisco Blanco-Vaca
Feb 10, 2012·Journal of the Royal Society, Interface·T SumnerA Warner
Dec 18, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Yao WangJianglin Fan
Dec 5, 2006·The Journal of Clinical Investigation·Daniel J Rader
Feb 17, 2009·BMC Medical Genetics·Konsta DuesingFernando Gibson
May 29, 2012·Journal of Lipid Research·Loren E SmithGiorgio Cavigiolio
Aug 21, 2013·Journal of Lipid Research·Wen-Liang Song, Garret A FitzGerald
Feb 13, 2014·PloS One·Timothy J Sontag, Catherine A Reardon
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·A RigottiM Krieger
Jan 14, 2003·Seminars in Cell & Developmental Biology·Peter Marschang, Joachim Herz
Feb 13, 2016·Clinica Chimica Acta; International Journal of Clinical Chemistry·Josep JulveFrancisco Blanco-Vaca
Jan 22, 2015·Meta Gene·Moushira Erfan ZakiMohamed Abdel-Hamid
Mar 1, 2007·Journal of Clinical Lipidology·William Virgil Brown
Apr 19, 2005·Obesity Research·Cristina Lara-CastroJosé R Fernández
Jan 6, 2010·Journal of Neurochemistry·Ian J MartinsRalph N Martins
May 7, 2014·Biochimica Et Biophysica Acta·Jan Albert Kuivenhoven, Robert A Hegele
Feb 28, 2004·Diabetes·Dominique SauvagetAgnès Ribeiro
Mar 2, 2013·PloS One·Youfeng YangGuangjie Cheng
Oct 7, 2004·Journal of Lipid Research·Lawrence W CastellaniAldons J Lusis
Jul 27, 2007·Journal of Lipid Research·Sonia Dugué-PujolAthina-Despina Kalopissis
Aug 3, 2005·Journal of Lipid Research·Maria C de BeerFrederick C de Beer

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.